Trials / Completed
CompletedNCT04992325
AS-OCT Study in Diabetic Retinopathy
Anterior Segment- Optical Coherence Tomography as Early Biomarker in Diabetic Retinopathy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Federico II University · Academic / Other
- Sex
- All
- Age
- 50 Years – 60 Years
- Healthy volunteers
- —
Summary
This study evaluates the corneal features using anterior segment - optical coherence tomography in patients affected by type 2 diabetes mellitus
Detailed description
To investigate the potential role of anterior segment-optical coherence tomography (AS-OCT) in identifying the corneal changes (in particular in total corneal, epithelial and stromal thicknesses) in patients affected by type 2 diabetes mellitus, without signs of diabetic retinopathy at fundus examination. The AS-OCT could represents a valid early biomarker in these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Anterior segment-optical coherence tomography | Each subject underwent anterior segment -optical coherence tomography to evaluate the total corneal, epthelium and stromal thicknesses. |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2021-04-25
- Completion
- 2021-04-30
- First posted
- 2021-08-05
- Last updated
- 2021-08-05
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04992325. Inclusion in this directory is not an endorsement.